Bitcoin surged over 4% to exceed $81,000 following the US midterm elections, despite a political shift that may bring tougher crypto regulations. The rally wiped out nearly $951 million in crypto liquidations, mostly from short positions. Analysts caution that the bounce is driven by leveraged trades rather than new spot buyers, with ETF outflows continuing and market focus shifting to inflation data and Federal Reserve policy. Investors should watch for potential price drops if support levels fail.
Bitcoin price action after the US midterm elections provides context for crypto markets. For readers following major cryptocurrencies on Pluang, here is the market snapshot as of Nov 05, 2026 00:31 WIB: out of 50 major cryptocurrencies, 45 rose and 4 fell today. Notable gainers include THETA with a 4.43% increase to Rp2.851, UNI up 4.33% to Rp138.430, and GRT rising 4.23% to Rp375.
Goldman Sachs Group, Inc. disclosed that it briefly held a combined stake exceeding 3% in Ontex Group NV shares as of October 27, 2026, with 566,115 voting rights and 1,965,157 financial instruments. However, by October 28, 2026, their combined posit...
BNP Paribas announced its monthly declaration of voting rights and shares as of October 31, 2026. The bank reported a total of 1,101,600,607 shares and an equal number of voting rights. This update is part of regulatory compliance under French commer...
Ontex disclosed that Goldman Sachs Group, Inc. crossed the 3% ownership threshold in Ontex shares on October 27, 2026, holding a combined total of 3.07% including voting rights and financial instruments. However, the next day, October 28, 2026, Goldm...
Neion Bio has appointed John A. Maga, Ph.D., as Head of Biologics and CMC to lead the development of biologic medicines using its Raptor platform, which produces proteins in transgenic chicken eggs. Maga brings over 25 years of biopharmaceutical expe...
The National Advertising Division (NAD) recommended that Good Life Meds discontinue claims about health benefits and personalization for its compounded Tirzepatide+ weight loss products after a challenge by Eli Lilly. NAD found that Good Life lacked ...
